Literature DB >> 23304100

Evacuation criteria after a nuclear accident: a personal perspective.

Richard Wilson1.   

Abstract

In any decision involving radiation a risk-risk or risk-benefit comparison should be done. This can be either explicit or implicit. When the adverse effect of an alternate action is less than the planned action, such as medical use of X rays or nuclear power in ordinary operation, the comparison is simple. But in this paper I argue that with the situation faced by the Japanese in Fukushima, the assumption that the risk of an alternate action is small is false. The risks of unnecessary evacuation exceeded the risk of radiation cancers hypothetically produced by staying in place. This was not realized by those that had to make a decision within hours. This realization suggests important changes, worldwide, in the guidelines for radiation protection in accident situations.

Entities:  

Keywords:  Evacuation; Nuclear; accident; radiation; risk

Year:  2012        PMID: 23304100      PMCID: PMC3526323          DOI: 10.2203/dose-response.11-058.Wilson

Source DB:  PubMed          Journal:  Dose Response        ISSN: 1559-3258            Impact factor:   2.658


  13 in total

1.  Peak and decline in cancer incidence, mortality, and prevalence at old ages.

Authors:  Charles Harding; Francesco Pompei; Richard Wilson
Journal:  Cancer       Date:  2011-09-22       Impact factor: 6.860

2.  The Windscale reactor accident--50 years on.

Authors:  Richard Wakeford
Journal:  J Radiol Prot       Date:  2007-08-29       Impact factor: 1.394

Review 3.  Health effects of relocation following disaster: a systematic review of the literature.

Authors:  Lori Uscher-Pines
Journal:  Disasters       Date:  2008-05-21

4.  Uncertainty estimates for low-dose-rate extrapolations of animal carcinogenicity data.

Authors:  H Guess; K Crump; R Peto
Journal:  Cancer Res       Date:  1977-10       Impact factor: 12.701

5.  Influence of total dose and dose rate in carcinogenicity studies.

Authors:  N A Littlefield; D W Gaylor
Journal:  J Toxicol Environ Health       Date:  1985

6.  The impact of marital status on cancer survival.

Authors:  O Kravdal
Journal:  Soc Sci Med       Date:  2001-02       Impact factor: 4.634

7.  Mortality and cancer registration experience of the Sellafield workers known to have been involved in the 1957 Windscale accident: 50 year follow-up.

Authors:  D McGeoghegan; S Whaley; K Binks; M Gillies; K Thompson; D M McElvenny
Journal:  J Radiol Prot       Date:  2010-08-27       Impact factor: 1.394

8.  Protracted radiation exposure and cancer mortality in the Techa River Cohort.

Authors:  L Yu Krestinina; D L Preston; E V Ostroumova; M O Degteva; E Ron; O V Vyushkova; N V Startsev; M M Kossenko; A V Akleyev
Journal:  Radiat Res       Date:  2005-11       Impact factor: 2.841

9.  Cancer mortality risk among workers at the Mayak nuclear complex.

Authors:  N S Shilnikova; D L Preston; E Ron; E S Gilbert; E K Vassilenko; S A Romanov; I S Kuznetsova; M E Sokolnikov; P V Okatenko; V V Kreslov; N A Koshurnikova
Journal:  Radiat Res       Date:  2003-06       Impact factor: 2.841

10.  Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.

Authors:  M M Le Beau; K S Albain; R A Larson; J W Vardiman; E M Davis; R R Blough; H M Golomb; J D Rowley
Journal:  J Clin Oncol       Date:  1986-03       Impact factor: 44.544

View more
  2 in total

1.  Special issue introduction.

Authors:  Bobby R Scott; Ludwik Dobrzyński
Journal:  Dose Response       Date:  2012-12-07       Impact factor: 2.658

2.  A Simple Survey of the Preparation Situation for Resident's Evacuation in Japanese Prefectures After the Fukushima Daiichi Nuclear Power Plant Accident.

Authors:  Takakiyo Tsujiguchi; Mizuki Sakamoto; Tomoki Koiwa; Yoko Suzuki; Kouya Ogura; Katsuhiro Ito; Kanako Yamanouchi; Ikuo Kashiwakura
Journal:  Front Public Health       Date:  2020-10-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.